I hope you guys are right about Vibrovein, but I have my doubts to be honest.
That news clip is well over a year old now and I don't think much product development has gone into it since then.
There was a similar clip for the AML cancer technology product around the same time and we have since returned that to the original vendor(s).
You'd have to think with a new management team that all products, IP & marketing plans are under review.
Anyway, nice to see some new names and interest in CGP and people prepared to give it more time. imho change was needed, so I'm prepared to give the new team several months to steady the ship.
CGP Price at posting:
4.0¢ Sentiment: Hold Disclosure: Held
